Hybrid weight-inclusive primary and metabolic care provider knownwell announced it will be listed as a care provider on pharma giant Eli Lilly’s digital healthcare platform LillyDirect.
knownwell touts itself as a hybrid weight-inclusive provider offering primary care and metabolic health services. The Boston-based company has brick-and-mortar locations in Texas, Chicago and Massachusetts.
Lilly launched LillyDirect in January of last year. The digital health experience offers patients with diabetes, obesity, sleep apnea, migraines, and memory and thinking issues access to in-person and virtual healthcare providers in all 50 states, educational information and a digital pharmacy for select Lilly medicines.
knownwell will be added to LillyDirect’s list of healthcare providers for patients seeking metabolic healthcare.
“Now, knownwell’s team of highly trained obesity experts can treat patients virtually in all 50 states, creating comprehensive care plans tailored to the individual’s needs,” Brooke Boyarsky Pratt, CEO and cofounder of knownwell, told MobiHealthNews in an email.
“These plans may include dietitian counseling, health coaching and anti-obesity medications. For individuals who may believe high-quality care is out of reach, we hope the opportunity to work seamlessly with knownwell clinicians within an insurance paradigm will make it easier for them to start and/or continue on their obesity care journey and improve their long-term, whole-person health.”
THE LARGER TREND
Earlier this year, knownwell announced it expanded into six brick-and-mortar clinics across the greater Chicago area. It will provide patients across the Midwest with virtual care access.
With the expansion, the company added 23 regional employees and its first market medical director and vice president of clinical partnerships, Dr. Anthony Auriemma, who previously served as the medical director at Ascension Medical Group Illinois Weight Loss Solutions.
Last year, the company acquired AI-enabled precision metabolic-health management company Alfie Health to help enhance its clinical decision-support offerings.
Alfie’s AI-enabled platform, ObesityRx, analyzes medical histories to determine which treatments will most effectively improve an individual’s metabolic health.
As part of the acquisition, standalone access to Alfie’s platform and Alfie-affiliated clinics were shut down, and ObestiyRx was integrated into knownwell’s care model.
knownwell launched in 2023 with $4.5 million in seed funding and later that year secured $20 million in Series A funding in a round led by Andreessen Horowitz (a16z) Bio + Health.
Trending Products
